Patent · US Active

Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors

US8450341B2 · kind B2 · utility

0Cited by

5References

12Claims

0Family size

Assignee

Almirall, S.A. · ES

Inventors

Paul Robert Eastwood · Romford, GB
Jacob Gonzalez Rodriguez · Barcelona, ES
Victor Giulio Matassa · Barcelona, ES

Key dates

Filing date	Apr 16, 2009
Grant date	May 28, 2013
Priority date	—
Expiry date	Jan 22, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure is directed to new inhibitors of the p38 mitogen-activated protein kinase having the general formula (I), processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.